
Kanceftri TZ 500mg/62.50mg Injection
Marketer
Fortune Life Sciences Private Limited
Salt Composition
Ceftriaxone (500mg) + Tazobactum (62.50mg)
Overview Kanceftri TZ 500mg/62.50mg Injection
Ceftazidime/Tazobactam 500mg/62.5mg injection is a dual-action antibiotic used to combat diverse bacterial infections. This medication works by inhibiting bacterial growth, thereby controlling infection spread. Administration must be solely under medical guidance. Complete the prescribed treatment regimen; premature cessation can compromise its effectiveness. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening side effects immediately to your physician. Seek immediate medical attention for allergic reactions (rash, itching, swelling, breathing difficulties). Inform your doctor of all other medications, and consult before use during pregnancy or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While it usually doesn't affect driving ability, refrain from driving if experiencing drowsiness or dizziness. Adequate rest, nutrition, and hydration are crucial for optimal recovery. Your doctor may order tests to monitor the medication's impact.
Uses of Kanceftri TZ 500mg/62.50mg Injection
Infections caused by bacteria
Major Benefits of Kanceftri TZ 500mg/62.50mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Kanceftri TZ 500mg/62.50mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Kanceftri TZ 500mg/62.50mg Injection:
This medication will be administered by your physician or their qualified staff. Self-medication is strictly prohibited.
How Kanceftri TZ 500mg/62.50mg Injection works:
Ceftriaxone/Tazobactam (Kanceftri TZ 500mg/62.50mg Injection) is a dual-action injectable drug. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial survival. Tazobactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Kanceftri TZ 500mg/62.50mg Injection consumption alongside alcohol poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Kanceftri TZ 500mg/62.50mg is typically deemed safe for pregnant individuals. Preclinical trials using animals have revealed minimal or no negative consequences for fetal development; nonetheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Kanceftri TZ 500mg/62.50mg Injection to breastfeeding mothers requires careful consideration. It's recommended to discontinue breastfeeding throughout the mother's course of treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Kanceftri TZ 500mg/62.50mg Injection could induce drowsiness, blurred vision, or dizziness. Refrain from driving if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Kanceftri TZ 500mg/62.50mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
For individuals with severe hepatic impairment, administering Kanceftri TZ 500mg/62.50mg Injection requires careful consideration and potential dosage modification. Medical consultation is advised. Dosage alteration of Kanceftri TZ 500mg/62.50mg Injection isn't suggested for those experiencing mild or moderate liver dysfunction.
What if you forget to take Kanceftri TZ 500mg/62.50mg Injection :
Omit a dose of Kanceftri TZ 500mg/62.50mg Injection? Seek medical advice immediately.
Facts to Know About Kanceftri TZ 500mg/62.50mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
